Search Results
Oct 29, 2025, 14:00 ET Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results
Highly Sensitized Patients Undergoing Transplantation. N Engl J Med 2017;377:442-453. DOI: 10.1056/NEJMoa16125 10_Winstedt L, et al. Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic
More news about: Hansa Biopharma AB
Oct 29, 2025, 13:57 ET Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results
Highly Sensitized Patients Undergoing Transplantation. N Engl J Med 2017;377:442-453. DOI: 10.1056/NEJMoa16125 10_Winstedt L, et al. Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic
More news about: Hansa Biopharma AB
Oct 29, 2025, 13:29 ET 'Wild Thoughts' Marketing Campaign for the New 2026 Jeep® Grand Cherokee Lets Animals Do the Talking
luxurious SUV in its class, from its three-row seating, heated front- and second-row seats, premium 19-speaker audio system, real walnut wood trim, 2.0L Hurricane 4 Turbo engine, best-in-class second-row legroom, driving range of 529 miles, most standard safety and security features in its class, and class-exclusive
More news about: Stellantis
Oct 29, 2025, 13:00 ET Dr. Kingsley R. Chin Attends ForbesBLK Summit 2025 as VIP Guest to Hear Robert F. Smith and Stephen A. Smith -- Aligns KIC Ventures' Spine HealthTech Vision with Vista Equity's Value-Building Model
guest-to-hear-robert-f-smith-and-stephen-a-smith--aligns-kic-ventures-spine-healthtech-vision-with-vista-equitys-value-building-model-302598571.html SOURCE KIC Ventures
More news about: KIC Ventures
Oct 29, 2025, 12:22 ET Sehen in völliger Dunkelheit: Wie die Automobil-Wärmebildkamera von Raytron die größte Herausforderung beim Offroad-Fahren bewältigt
Automobilherstellern wie BYD, Geely und GWM zusammen und liefert fortschrittliche Nachtsichtgeräte für automatisierte Fahrsysteme der Klassen L2, L3 und sogar L4, die das Fahren bei Nacht für alle sicherer machen. Für weitere InformationenE-Mail:
More news about: Raytron Technology Co., Ltd.
Oct 29, 2025, 11:25 ET Ezurio and onceLabs Partner to Accelerate Bluetooth Channel Sounding Development
and Cellular, onceLabs helps teams move quickly from prototype to production. Ezurio's Nordic-based modules – BL54L15 and BL54L15µ (nRF54L), BL5340 (nRF53), and BL654 (nRF52)-- combined with onceLabs' application layer software, delivers a seamless path from concept to connected
More news about: Ezurio
Oct 29, 2025, 11:09 ET I-MAB (Nasdaq: IMAB)正式更名為新橋生物（NovaBridge Biosciences；Nasdaq: NBP），股票交易將於 2025 年 10 月 30 日正式生效，新品牌標誌著其向全球生物科技平台型公司的戰略轉型。
io平分全球權益（大中華區和韓國除外）。 Ragistomig 是一款抗 PD-L1×4-1BB 的雙特異性抗體。基於一期臨床數據，目前開展的1b期研究旨在擴大治療窗口，預計將在2026年下半年產生結果。該項目正與ABL Bio聯合開發。
More news about: 新桥生物
Oct 29, 2025, 10:30 ET Herb Extract Market to Reach $23.8 billion, Globally, by 2035 at 9.3% CAGR: Allied Market Research
longa Linn), ginger (Zingiber officinale Roscoe), Indian pennywort (Centella asiatica), aloe (Aloe vera (L.) Burm.f.), Fah Talai Jone (Andrographis paniculata), Indian gooseberry (Phyllanthus emblica L.), Krachai Dum (Kaempferia parviflora), Krathom (Mitragyna speciosa), and others. Region-wise,
More news about: Allied Market Research
Oct 29, 2025, 10:17 ET INTERNATIONAL AIRPORT FINANCE, S.A. ANNOUNCES CONSENT SOLICITATION RELATED TO THE 12.000% SENIOR SECURED NOTES DUE 2033
(CUSIP Nos. 45900T AA0 / E6R69L AA2;ISIN Nos. US45900TAA07 / USE6R69LAA27) MADRID, Oct. 29, 2025 /PRNewswire/ -- International Airport Finance,
More news about: International Airport Finance, S.A.
Oct 29, 2025, 10:00 ET D2L Survey Finds AI-Enabled Learning Tools Can Help Unlock Time Savings for Higher Ed Professionals
www.D2L.com. The D2L family of companies includes D2L Inc., D2L Corporation, D2L Ltd, D2L Australia Pty Ltd, D2L Europe Ltd, D2L Asia Pte Ltd, D2L India Pvt Ltd, D2L Brasil Soluções de Tecnologia para Educação Ltda and D2L Sistemas de Aprendizaje Innovadores, S. D2 R.L de
More news about: D2L
Oct 29, 2025, 09:57 ET Targeting the New Energy Frontier in the Middle East: LEPAS Signs UAE Distribution Agreement with Al Ghurair Group
the brand's core value of"Elegant Driving." Notably, Mr. Ban Ki-moon, the 8th Secretary-General of the United Nations, visited the LEPAS L8, LEPAS L6, and LEPAS L4 models during the event and praised LEPAS's forward-thinking vision and technological strength, further reinforcing its commitment to sustainable
More news about: Chery Group
Oct 29, 2025, 09:15 ET VisionWave and PVML Enter Execution Phase of Secure-AI Partnership Following Founders Meeting in Tel Aviv
The working sessions brought together Douglas L. Davis, Executive Chairman of VisionWave; Haggai Ravid, Audit Committee Chair of VisionWave; and PVML co-founders Dr. Shachar Schnapp (CEO)
More news about: VisionWave Holdings, Inc
Oct 29, 2025, 09:15 ET VisionWave and PVML Enter Execution Phase of Secure-AI Partnership Following Founders Meeting in Tel Aviv
The working sessions brought together Douglas L. Davis, Executive Chairman of VisionWave; Haggai Ravid, Audit Committee Chair of VisionWave; and PVML co-founders Dr. Shachar Schnapp (CEO)
More news about: VisionWave Holdings, Inc
Oct 29, 2025, 09:00 ET Field & Stream Pet Food Co. launches Pack Provisions dog food product line
as Chicken and Rice Dinner. "Active dogs need nutrition that supports energy levels and promotes healthy recovery," said Kathy L. Gross, PhD, PAS, DACAN, an experienced pet nutritionist and adjunct professor at Kansas State University. "With carefully selected ingredients that fuel
More news about: Field & Stream Pet Food Co.
Oct 29, 2025, 09:00 ET FDA Accepts BioMarin's PALYNZIQ® (pegvaliase-pqpz) Supplemental Biologics License Application for Priority Review to Expand Use to Adolescents Aged 12-17 with Phenylketonuria
(Phe)-metabolizing enzyme indicated to reduce blood Phe levels in adult patients with phenylketonuria who have uncontrolled blood Phe levels greater than 600 micromol/L on existing management. BOXED WARNING: RISK OF ANAPHYLAXIS
More news about: BioMarin Pharmaceutical Inc.
Oct 29, 2025, 08:48 ET Akston Pioneers a New Generation of Cancer Therapy for Dogs in Clinical Trial Launch
access or tolerate conventional monoclonal antibody treatments. The Ambifect® version builds on Akston's anti-cPD-L1 monoclonal antibody (mAb), designed to target and block the cPD-L1 protein on cancer cells, currently in clinical trial for dogs with urothelial (bladder) carcinoma, and on track for
More news about: Akston
Oct 29, 2025, 08:37 ET FastWave Medical Presents First-in-Human and Pre-Clinical Data for Sola™ Coronary Laser IVL System at TCT 2025
FastWave Medical presented new first-in-human (FIH) and pre-clinical data for its Sola™ coronary laser intravascular lithotripsy (L-IVL) system at TCT 2025 (Transcatheter Cardiovascular Therapeutics), the world's leading symposium in interventional cardiovascular medicine organized by
More news about: FastWave Medical
Oct 29, 2025, 08:28 ET ADAMA Reports Third Quarter and First Nine Months 2025 Results
USD L 3M
More news about: ADAMA Ltd.
Oct 29, 2025, 08:05 ET Johnson & Johnson announces first head-to-head study comparing IMAAVY™ with an alternative FcRn blocker in generalized myasthenia gravis (gMG) at AANEM Annual Meeting
respectively.1 "The EPIC study marks an important step forward in advancing care for people living with gMG," said Leonard L. Dragone, M.D., Ph.D., Disease Area Leader, Autoantibody and Rheumatology, Johnson & Johnson Innovative Medicine. "By directly comparing IMAAVY to
More news about: Johnson & Johnson
Oct 29, 2025, 08:00 ET A Breakthrough in Color Measurement Is Coming: The HunterLab Agera L2
Coming this November: Agera L2. HunterLab's next-gen spectrophotometer is redefining how the world sees color. The Agera L2 represents a major advance in HunterLab's ongoing mission to align instrumental color measurement
More news about: HunterLab
Oct 29, 2025, 08:00 ET Target ALS premieres "Everyone Lives: Turning Vision Into Reality," a short film following Dan Doctoroff's journey to transform ALS research
exclusive post-film Q&A, featuring leading voices from the ALS research community: Daniel L. Doctoroff, Founder & Board Chair, Target ALS; Founder & Former CEO, Sidewalk Labs; Former CEO, Bloomberg LP; Former Deputy Mayor of Economic
More news about: Target ALS
Oct 29, 2025, 08:00 ET CYMBIOTIKA WELLNESS BAR UNVEILS EXCLUSIVE PESO PLUMA SIGNATURE SMOOTHIE AT FONTAINEBLEAU LAS VEGAS
including: Signature Smoothies: Banana Nut Smoothie with Magnesium L-Theronate Bowls: Tropical Sunshine Açaí Bowl with Irish Sea Moss
More news about: Cymbiotika
Oct 29, 2025, 07:30 ET L7 Informatics Named Top Innovator in 2025 Frost & Sullivan Frost Radar™ for Pharma and Biotech LIMS
sciences." About L7 Informatics, Inc.L7 Informatics, Inc. is a leading provider of integrated scientific data and analytics solutions. Its unified platform, L7|ESP®, enables seamless data integration, advanced analytics, and collaborative
More news about: L7 Informatics
Oct 29, 2025, 06:57 ET AEP Reports Third-Quarter 2025 Operating Earnings, Updated Capital Plan Drives New Long-Term Growth Rate
(l)
More news about: American Electric Power
Oct 29, 2025, 06:30 ET Entergy reports third quarter 2025 financial results
(l)
More news about: Entergy Corporation